Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 November 1993 | Volume 119 Issue 9 | Pages 882-886
Objective: To determine the effect of cigarette smoking on proximal duodenal mucosal bicarbonate secretion, an important defense mechanism against acid and peptic damage.
Design: Prospective study.
Setting: Clinical research laboratory in a university hospital.
Patients: Thirteen healthy adults (7 smokers and 6 nonsmokers) who had no history of peptic ulcer disease.
Interventions: Participants smoked (1 cigarette/15 min during a period of 1 hour, smokers only) or sham smoked (puffing on an unlit cigarette) during duodenal perfusion with either saline, hydrochloric acid, or prostaglandin E2 (PGE2).
Measurements: Collection of proximal duodenal secretions using a modified duodenal tube with occluding balloons and quantitation of duodenal mucosal bicarbonate secretion.
Results: During sham smoking both smokers and nonsmokers had comparable basal as well as H+-stimulated and PGE2-stimulated duodenal mucosal bicarbonate secretion. Compared with sham smoking, smoking did not significantly alter basal bicarbonate secretion (201 µmol/cm per hour [95% CI, 152 to 250 µmol/cm per hour] compared with 178 µmol/cm per hour [CI, 134 to 222 µmol/cm per hour], respectively). However, compared with sham smoking, smoking markedly reduced (P < 0.01) the increase in duodenal bicarbonate secretion in response to luminal acidification by approximately 80% (from 242 µmol/cm per hour [CI, 41 to 443 µmol/cm per hour] to 53 µmol/cm per hour [CI, 107 to 197 µmol/cm per hour]); a decrease was observed in each participant. In contrast, smoking had no significant effect on the response to luminal PGE2.
Conclusions: Cigarette smoking markedly inhibited acid-stimulated human duodenal mucosal bicarbonate secretion. This adverse effect of smoking may, at least in part, explain the role of cigarette smoking in the pathogenesis and natural history of duodenal ulcer disease.
We examined the effect of cigarette smoking on basal as well as on acid- and PGE2-stimulated human proximal duodenal mucosal bicarbonate secretion. We selected luminal acidification and PGE2 as agonists because acid is a major physiologic stimulus for duodenal mucosal bicarbonate secretion and because acid-stimulated bicarbonate secretion is mediated, at least in part, by endogenous PGE2 [31, 32].
Six healthy nonsmoking volunteers (one woman and five men; mean age, 45 years; range, 35 to 60 years) with no previous history of peptic ulcer disease and seven healthy chronic smokers (all men; mean age, 41 years; range, 27 to 56 years) with no previous history of peptic ulcer disease participated in these studies. All smokers smoked at least one pack of cigarettes per day. The protocol was approved by the University of California at San Diego Human Subjects Committee; all participants gave written informed consent.
On the first test day a double-lumen nasogastric tube was fluoroscopically positioned so that the tip was in the middle of the gastric antrum. Basal gastric acid secretion and the response to pentagastrin, 6 µg/kg body weight administered subcutaneously (Ayerst Laboratories; New York, New York), were determined. This procedure ensured that each participant had normal gastric secretory function and also introduced the participants to intubation methods. Basal and maximal acid outputs in smokers and nonsmokers were within normal limits and not significantly different between groups: 5.2 mmol/h (95% CI, 2.5 to 7.9 mmol/h) and 40.3 mmol/h (CI, 35.4 to 45.2 mmol/h) compared with 7.2 mmol/h (CI, 0.8 to 13.6 mmol/h) and 41.2 mmol/h (CI, 28.0 to 54.0 mmol/h), respectively.
Experimental Design
The nonsmokers participated in two studies and the smokers participated in four separate studies. The nonsmokers did not participate in the smoking experiments. All experiments were performed after a 12-hour fast and, in the smokers, after abstention from smoking for 12 hours. The order of experiments was randomized and only a single test was done on a single day. After two 15-minute basal collections in each study, participants "puffed" on either an unlit cigarette (sham smoking) or smoked one cigarette (Marlboro [18 mg tar, 1.1 mg nicotine [33], Philip Morris Inc.; Richmond, Virginia) per 15-minute period for a total of 60 minutes.
The methods used to isolate the proximal duodenal test segment free from gastric, pancreaticobiliary, and intestinal secretions have been described and validated previously [34-36]. In brief, a 4-cm segment of the proximal duodenum (the duodenal bulb) was isolated between two balloons. The isolated test segment was perfused with 154 mmol/L NaCl (2 mL/min, 37 °C) containing Carbon-14-polyethylene glycol as a nonabsorbable marker. The effluent was collected in 15-minute intervals; pH and PCO2 were measured (Micro 13, Instrument Laboratories; Lexington, Massachusetts) in triplicate anaerobically and (HCO3) was determined by using the Henderson-Hasselbalch equation. Bicarbonate outputs were calculated in 15-minute intervals and are expressed as µmole/cm x hour. To ensure that the isolated proximal duodenal test segment remained uncontaminated with gastric and pancreaticobiliary secretions, markers of gastric (phenol red infused into the stomach) and pancreaticobiliary secretions (bilirubin and trypsin) were measured at 15-minute intervals. Experiments during which phenol red staining or trypsin greater than 10 U/mL or bile staining occurred were discarded. Almost all duodenal collections were free from contamination. The trypsin content in the remaining samples was only 2.3 U/mL (range, 1.8 to 2.7 U/mL), compared with a trypsin concentration of approximately 110 U/mL distal to the segment [34]. Further, the trypsin content in the isolated test segment was unrelated to bicarbonate secretion [34].
Basal bicarbonate secretion was measured for two 15-minute periods. The participants then either began sham smoking or actual smoking for two more 15-minute periods (periods 1 and 2) during which time the isolated duodenal test segment was still perfused with 154 mmol/L NaCl. To determine the effect of intraluminal acidification, the isolated duodenal segment was perfused for 5 minutes with 100 mmol/L HCl (iso-osmolar by addition of NaCl) at 37 °C, equivalent to 2 mmol H+ [34]. After acidification, the duodenum was flushed with 154 mmol/L NaCl and acid-stimulated bicarbonate secretion was measured for 1 hour (periods 3 to 6).
The response to PGE2 was also studied after measuring basal bicarbonate. Natural PGE2 (Upjohn, Kalamazoo, Michigan) was infused at 8.33 µg/mL in 154 mmol/L NaCl into the isolated test segment for 30 minutes (periods 3 and 4), equivalent to 1.4 µmol of PGE2. Bicarbonate secretion was measured for two more 15-minute periods thereafter (periods 5 and 6).
Calculations and Statistical Analysis
Corrected bicarbonate outputs were determined at 15-minute intervals using standard equations based on the recovery of Carbon-14-polyethylene glycol [37]. Results are expressed as means and 95% confidence intervals. All results were calculated from individual data. Net bicarbonate outputs indicate responses after the basal secretion was subtracted. Two-way analysis of variance and the Student t-test for paired and unpaired data were used in the statistical analysis, which was done with the computer program SPIDA (Statistical Package for Interactive Data Analysis; Statistical Laboratory, Macquarie University, New South Wales, Australia). Differences were considered significant if P < 0.05.
In the sham-smoking studies, mean basal duodenal mucosal bicarbonate outputs in nonsmokers and smokers were comparable: 185 µmol/cm per hour (CI, 113 to 257 µmol/cm per hour) and 178 µmol/cm per hour (CI, 134 to 222 µmol/cm per hour), respectively. These values are comparable to those reported previously in this and other laboratories [34-36]. In nonsmokers sham smoking had no significant effect on unstimulated bicarbonate secretion Figure 1, top], whereas in smokers sham-smoking caused a modest increase. During sham smoking, bicarbonate secretion increased significantly in response to luminal acidification in both smokers and nonsmokers Figure 1, top). The increases above basal were comparable: 242 µmol/cm per hour (CI, 41 to 443 µmol/cm per hour) and 220 µmol/cm per hour (CI, 97 to 343 µmol/cm per hour), respectively (145% and 120% above basal measurements, respectively). ARTICLE
Cigarette Smoking Inhibits Acid-stimulated Duodenal Mucosal Bicarbonate Secretion
Many studies have reported that cigarette smoking is associated with an increased risk for developing a duodenal ulcer as well as with a greater incidence of ulcer-related complications, including death [1-6]. Further, once the duodenal ulcer disease has been established, cigarette smoking delays ulcer healing and increases the risk for recurrences [7-15]. Cigarette smoking, therefore, induces an imbalance between aggressive and defensive factors in the pathogenesis of peptic ulcer, but the precise mechanisms leading to this imbalance are unknown. The reported effect of smoking on gastric acid secretion is inconsistent, ranging from no change to an increase or a decrease in acid secretion [16-22]. Other suggested mechanisms include smoking-induced increase in gastric emptying rates [23, 24] and a decrease in pancreatic bicarbonate secretion [25-27]. Recent evidence indicates that smoking decreases the gastroduodenal mucosal synthesis of prostaglandin E2 (PGE2) [28-30], a key factor in the regulation of mucosal defense including the stimulation of duodenal mucosal bicarbonate secretion [31].
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Participants
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Acid-stimulated Bicarbonate Secretion
|
The mean basal duodenal mucosal bicarbonate output of smokers before smoking was comparable to the sham-smoking studies: 201 µmol/cm per hour (CI, 152 to 250 µmol/cm per hour) and 178 µmol/cm per hour [CI, 134 to 222 µmol/cm per hour], respectively. Compared with sham smoking, actual smoking failed to alter basal bicarbonate secretion Figure 1, bottom). However, whereas luminal acidification resulted in a significant increase in bicarbonate secretion during sham smoking, smoking almost completely abolished the acid-stimulated response Figure 1, bottom). The peak increase in response to luminal acid during smoking (53 µmol/cm per hour [CI, 33 to 139 µmol/cm per hour], 26% above basal) was only approximately 20% of the response observed during sham smoking (242 µmol/cm per hour [CI, 41 to 443 µmol/cm per hour], 145% above basal measurements). Further, the net total 30-minute bicarbonate outputs (periods 2 to 4) during sham smoking was 315 µmol/30 min (CI, 26 to 604 µmol/30 min) compared with only 45 µmol/30 min (CI, 107 to 197 µmol/30 min) during smoking (P < 0.01). Compared with sham smoking, cigarette smoking reduced the peak bicarbonate output in response to luminal acidification in each of the participants studied.
Prostaglandin-E2-stimulated Bicarbonate Secretion
During sham smoking, the basal bicarbonate secretion of the smokers did not differ significantly from the nonsmokers: 183 µmol/cm per hour (CI, 132 to 234 µmol/cm per hour) and 160 µmol/cm per hour (CI, 103 to 217 µmol/cm per hour), respectively. Further, during sham smoking PGE2 significantly increased bicarbonate secretion in smokers and nonsmokers Figure 2, top); the peak increases above basal measurements were comparable in the two groups: 126 µmol/cm per hour (CI, 62 to 190 µmol/cm per hour) and 121 µmol/cm per hour (CI, 21 to 221 µmol/cm per hour), respectively (73% and 114% above basal measurements, respectively).
|
Compared with sham smoking, smoking failed to alter basal and PGE2-stimulated mucosal bicarbonate secretion Figure 2, bottom). The integrated net 30-minute responses to PGE2 during sham smoking and smoking were comparable: 159 µmol/30 min (CI, 31 to 288 µmol/30 min) and 122 [5 to 249] µmole/30 min, respectively. During smoking, however, the alkaline response was delayed and did not reach statistical significance until cigarette smoking was discontinued Figure 2, bottom).
Discussion
|
|---|
|
|
|---|
Cigarette smoking inhibited acid-stimulated, but not PGE2-stimulated, duodenal mucosal bicarbonate secretion. Cryer and colleagues [30] reported recently that duodenal as well as gastric PGE2 and PGF2a concentrations measured in mucosal biopsies were significantly diminished in cigarette smokers compared with nonsmokers. Because the stimulatory effect of duodenal acidification is probably mediated in part through the release of PGE2 [38], taken together, these results suggest that smoking may inhibit the response to luminal acidification through inhibition of acid-induced release of PGE2. The inhibitory effect of smoking on human duodenal mucosal bicarbonate secretion is undoubtedly related to the constituents of tobacco smoke itself because sham smoking had no effect. Our study does not, however, allow us to formulate any firm conclusions as to which of the many constituents of tobacco smoke produces this effect. Nicotine itself is not likely to be the mediator, because intravenous infusion of nicotine, in doses corresponding to those occurring during cigarette smoking, had no effect on the duodenal mucosal bicarbonate secretion in anesthetized rabbits [39]. Other, more likely, mechanisms include inhibition of endogenous prostaglandin production [28-30], the stimulation of sympathetic neurons, or both [39].
Limited information is available regarding the effect of tobacco smoke on duodenal mucosal bicarbonate secretion; we are aware of no studies that have examined this phenomenon in humans. Granstam and colleagues [39] observed that tobacco smoke inhibited basal duodenal mucosal bicarbonate secretion in rodents. (The effect of smoking on stimulated duodenal bicarbonate output was not reported.) Our findings differed somewhat from theirs because we saw no effect of cigarette smoking on human basal bicarbonate output. This discrepancy may have been caused by differences in the quantity of tobacco smoke administered to animals, by differences between the species, or both.
The ulcerogenic effect of cigarette smoking is probably related to either stimulation of "aggressive," inhibition of "defensive" factors, or both. Stimulation of aggressive factors is less likely because the effect of smoking on a major aggressive factor, gastric acid secretion, is inconsistent (ranging from no change to either inhibition or stimulation [16-22]). Information on the effect of smoking on duodenal defensive factors is scarce. Cigarette smoking has been reported to inhibit human "pancreatic" bicarbonate secretion [20, 25-27]. However, these studies examined mixed duodenal secretions (that is, pancreatic as well as duodenal plus hepatobiliary). Therefore, the decreases in luminal bicarbonate content attributed to a pancreatic effect may have been largely caused by smoking-induced decreases in mucosal or hepatobiliary bicarbonate secretion or both rather than by a specific effect on the pancreas. We selectively measured the proximal duodenal mucosal bicarbonate secretion.
Bicarbonate secreted by the gastroduodenal mucosa creates a pH gradient across the mucus layer immediately adjacent to the surface epithelium; pH at the cell membrane remains nearly neutral despite acidic luminal pH [31, 32, 40]. The juxtamucosal neutralization of acid by surface epithelium is an important factor in the protection of the duodenal mucosa from acid-peptic injury [31, 32, 41]. Further, in humans the major and minor pancreatic ducts enter the duodenum at approximately 6 to 10 cm distal to the pylorus [42]. Therefore, acid neutralization and inactivation of pepsins in the duodenal bulb are achieved, at least in part, by intrinsic mucosal bicarbonate production. Smoking-induced inhibition of mucosal bicarbonate secretion, therefore, would impair acid neutralization and probably pepsin inactivation by the duodenal bulb. This finding may contribute to the clinical observation that cigarette smokers are predisposed to develop duodenal ulcer disease and have delayed ulcer healing and a greater risk for ulcer-related complications than nonsmokers.
These data have been published in abstract form: Gastroenterology. 1992; 102:A32.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Trowell OA. The relation of tobacco smoking to the incidence of chronic duodenal ulcer. Lancet. 1934; 1:808-9.
2. Friedman GD, Siegelaub AB, Seltzer CC. Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med. 1974; 290:469-73.
3. Solomon TE, Jacobson ED. Cigarette smoking and duodenal-ulcer disease. N Engl J Med. 1972; 286:1212-3.
4. Chiverton SG, Hunt RH. Smoking and duodenal ulcer disease. J Clin Gastroenterology. 1989; 11(Suppl 1):S29-S33.
5. Harrison AR, Elashoff JD, Grossman MI. Smoking and Health. A Report to the Surgeon General. Washington, DC: U.S. Department of Health, Education and Welfare; 1979:9.3-9.21.
6. Doll R, Hill AB. Mortality in relation to smoking. Ten years observations of British doctors. Br Med J. 1964; 1:1399-410.
7. Korman MG, Shaw RG, Hansky J, Schmidt GT, Stern AI. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology. 1981; 80:1451-3.
8. Massarrat S, Eisenmann A. Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment. Gut. 1981; 22:97-102.
9. Sonnenberg A, Muller-Lissner SA, Vogel E, Schmid P, Gonvers JJ, Peter P. Predictors of duodenal ulcer healing and relapse. Gastroenterology. 1981; 81:1061-7.
10. Gugler R, Rohner HG, Kratochvil P, Brandstatter G, Schmitz H. Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut. 1982; 23:866-71.
11. Korman MG, Hansky J, Merrett AC, Schmidt GT. Ranitidine in duodenal ulcer: incidence of healing and effect of smoking. Dig Dis Sci. 1982; 27:712-5.
12. Korman MG, Hansky J, Eaves ER, Schmidt GT. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology. 1983; 85:871-4.
13. Sontag S, Graham DY, Belsito A, Weiss J, Farley A, Grunt R, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med. 1984; 311:689-93.
14. Hull DH, Beale PJ. Cigarette smoking and duodenal ulcer. Gut. 1985; 26:1333-7.
15. Ostensen H, Gudmundsen TE, Ostensen M, Burhol PG, Bonnevie O. Smoking, alcohol, coffee, and familial factors: any associations with peptic ulcer disease? A clinically and radiologically prospective study. Scand J Gastroenterol. 1985; 20:1227-35.
16. Wilkinson AR, Johnston D. Inhibitory effect of cigarette smoking on gastric secretion stimulated by pentagastrin in man. Lancet. 1971; 2:628-32.
17. Wilkinson A, Johnston D. Effect of smoking cigarettes on pentagastrin-stimulated gastric secretion in normal persons and patients with peptic ulcer. Gut. 1969; 10:415.
18. Debas HT, Cohen MM, Holubitsky IB, Harrison RC. Effect of cigarette smoking on human gastric secretory responses. Gut. 1971; 12: 93-6.
19. Whitecross DP, Clarke AD, Piper DW. The effect of cigarette smoking on human gastric secretion. Scand J Gastroenterol. 1974; 9:399- 403.
20. Murthy SN, Dinoso VP Jr, Clearfield HR, Chey WY. Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology. 1977; 73: 758-61.
21. Whitfield PF, Hobsley M. Maximal gastric secretion in smokers and non-smokers with duodenal ulcer. Br J Surg. 1985; 72:955-7.
22. Whitfield PF, Hobsley M. Comparison of maximal gastric secretion in smokers and non-smokers with and without duodenal ulcer. Gut. 1987; 28:557-60.
23. Parente F, Lazzaroni M, Sangaletti O, Baroni S, Bianchi Porro G. Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Gut. 1985; 26:1327-32.
24. Malesci A, Basilico M, Bersani M, Bonato C, Ballarin E, Ronchi G. Serum pepsinogen I elevation in cigarette smokers. Scand J Gastroenterol. 1988; 23:602-6.
25. Brown P. The influence of smoking on pancreatic function in man. Med J Aust. 1976; 2:290-3.
26. Bochenek WJ, Koronczewski R. Effects of cigarette smoking on bicarbonate and volume of duodenal contents. Am J Dig Dis. 1973; 18:729-33.
27. Bynum TE, Solomon TE, Johnson LR, Jacobson ED. Inhibition of pancreatic secretion in man by cigarette smoking. Gut. 1972; 13: 361-5.
28. Quimby GF, Bonnice CA, Burstein SH, Eastwood GL. Active smoking depresses prostaglandine synthesis in human gastric mucosa. Ann Intern Med. 1986; 104:616-9.
29. McCready DR, Clark L, Cohen MM. Cigarette smoking reduces human gastric luminal prostaglandin E2. Gut. 1985; 26:1192-6.
30. Cryer B, Lee E, Feldman M. Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging. Ann Intern Med. 1992; 116:636-40.
31. Flemstrom G, Turnberg LA. Gastroduodenal defence mechanisms. Clin Gastroenterology. 1984; 13:327-54.
32. Flemstrom G. Gastric and duodenal mucosal bicarbonate secretion. In: Johnson LR, Christensen J, Jackson MJ, Jacobson ED, Walsh JH; eds. Physiology of the Gastrointestinal Tract. 2d ed. New York: Raven Press; 1987:1011-30.
33. Federal Trade Commission report of "tar" and nicotine content of smoke of 167 varieties of cigarettes. Washington, D.C.: Federal Trade Commission; 1978:17.
34. Isenberg JI, Hogan DL, Koss MA, Selling JA. Human duodenal mucosal bicarbonate secretion. Evidence for basal secretion and stimulation by hydrochloric acid and a synthetic prostaglandin E1 analogue. Gastroenterology. 1986; 91:370-8.
35. Ainsworth MA, Kjeldsen J, Schaffalitzky de Muckadell OB. Morphine inhibits secretion of bicarbonate from the human duodenal mucosa. Possible role of endogenous opioids in the regulation of human duodenal mucosal bicarbonate secretion. Scand J Gastroenterol. 1990; 25:1066-75.
36. Knutson L, Flemstrom G. Duodenal mucosal bicarbonate secretion in man. Stimulation by acid and inhibition by the
2-adrenoceptor agonist clonidine. Gut. 1989; 30:1708-15.
37. Stern AI, Hogan DL, Isenberg JI. A new method for quantitation of ion fluxes across the in vivo human gastric mucosa. Gastroenterology. 1984; 86:60-70.
38. Selling JA, Hogan DL, Aly A, Koss MA, Isenberg JI. Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects. Ann Intern Med. 1987; 106:368-71.
39. Granstam SO, Jonson C, Fandriks L, Holm L, Flemstrom G. Effects of cigarette smoke and nicotine on duodenal bicarbonate secretion in the rabbit and the rat. J Clin Gastroenterol. 1990; 12(Suppl 1): S19-S24.
40. Quigley EM, Turnberg LA. pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients. Gastroenterology. 1987; 92:1876-84.
41. Wenzl E, Feil W, Starlinger M, Schiessel R. Alkaline secretion. A protective mechanism against acid injury in rabbit duodenum. Gastroenterology. 1987; 92:709-15.
42. Millbourne E. On excretory ducts of the pancreas in man with special reference to their relations to each other, to common bile duct and to duodenum; radilogical and anatomical study. Acta Anat. 1950; 9:1-34.
This article has been cited by other articles:
![]() |
S. Levenstein The Very Model of a Modern Etiology: A Biopsychosocial View of Peptic Ulcer Psychosom Med, March 1, 2000; 62(2): 176 - 185. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||